| Quarter | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 296 | 313 | 358 | 352 | 412 | 476 | 514 | 534 | 576 | |
Growth YoY Revenue Growth YoY% | 39.2 | 51.7 | 43.5 | 51.6 | 39.9 | ||||
| 234 | 244 | 286 | 273 | 318 | 367 | 395 | 405 | 432 | |
| 62 | 70 | 72 | 79 | 94 | 108 | 119 | 129 | 144 | |
OPM OPM% | 20.8 | 22.3 | 20.2 | 22.4 | 22.9 | 22.7 | 23.1 | 24.2 | 25.0 |
| 3 | 0 | 0 | 1 | 1 | 4 | 3 | 6 | 2 | |
Interest Expense Interest ExpenseCr | 7 | 8 | 12 | 11 | 11 | 10 | 10 | 9 | 11 |
Depreciation DepreciationCr | 8 | 9 | 10 | 10 | 12 | 12 | 12 | 15 | 18 |
PBT PBTCr | 49 | 53 | 51 | 60 | 72 | 91 | 99 | 110 | 117 |
| 15 | 15 | 15 | 16 | 18 | 18 | 22 | 26 | 27 | |
| 34 | 38 | 36 | 43 | 54 | 73 | 77 | 85 | 90 | |
Growth YoY PAT Growth YoY% | 56.2 | 91.2 | 111.8 | 95.8 | 67.9 | ||||
NPM NPM% | 11.7 | 12.2 | 10.1 | 12.3 | 13.1 | 15.3 | 14.9 | 15.9 | 15.7 |
| 2.3 | 2.5 | 2.4 | 2.8 | 3.5 | 4.5 | 4.7 | 5.1 | 5.5 |
| Quarter | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 296 | 313 | 358 | 352 | 412 | 476 | 514 | 534 | 576 | |
Growth YoY Revenue Growth YoY% | 39.2 | 51.7 | 43.5 | 51.6 | 39.9 | ||||
| 234 | 244 | 286 | 273 | 318 | 367 | 395 | 405 | 432 | |
| 62 | 70 | 72 | 79 | 94 | 108 | 119 | 129 | 144 | |
OPM OPM% | 20.8 | 22.3 | 20.2 | 22.4 | 22.9 | 22.7 | 23.1 | 24.2 | 25.0 |
| 3 | 0 | 0 | 1 | 1 | 4 | 3 | 6 | 2 | |
Interest Expense Interest ExpenseCr | 7 | 8 | 12 | 11 | 11 | 10 | 10 | 9 | 11 |
Depreciation DepreciationCr | 8 | 9 | 10 | 10 | 12 | 12 | 12 | 15 | 18 |
PBT PBTCr | 49 | 53 | 51 | 60 | 72 | 91 | 99 | 110 | 117 |
| 15 | 15 | 15 | 16 | 18 | 18 | 22 | 26 | 27 | |
| 34 | 38 | 36 | 43 | 54 | 73 | 77 | 85 | 90 | |
Growth YoY PAT Growth YoY% | 56.2 | 91.2 | 111.8 | 95.8 | 67.9 | ||||
NPM NPM% | 11.7 | 12.2 | 10.1 | 12.3 | 13.1 | 15.3 | 14.9 | 15.9 | 15.7 |
| 2.3 | 2.5 | 2.4 | 2.8 | 3.5 | 4.5 | 4.7 | 5.1 | 5.5 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 263 | 315 | 314 | 394 | 854 | 1,284 | 1,754 | 2,100 |
Growth Revenue Growth% | 19.6 | -0.4 | 25.5 | 117.0 | 50.4 | 36.6 | 46.3 | |
| 182 | 223 | 353 | 375 | 699 | 1,020 | 1,354 | 1,600 | |
| 81 | 92 | -39 | 18 | 155 | 264 | 400 | 500 | |
OPM OPM% | 30.6 | 29.1 | -12.5 | 4.7 | 18.1 | 20.6 | 22.8 | 23.8 |
| 18 | 10 | 17 | 25 | 19 | 4 | 8 | 14 | |
Interest Expense Interest ExpenseCr | 6 | 9 | 10 | 19 | 31 | 37 | 42 | 41 |
Depreciation DepreciationCr | 18 | 29 | 34 | 36 | 39 | 37 | 45 | 57 |
PBT PBTCr | 74 | 63 | -66 | -11 | 103 | 195 | 321 | 417 |
| 25 | 32 | 1 | 6 | 12 | 60 | 74 | 92 | |
PAT PATCr | 49 | 31 | -67 | -17 | 91 | 134 | 247 | 325 |
Growth PAT Growth% | -37.9 | -318.7 | 74.8 | 638.9 | 47.6 | 83.6 | 89.4 | |
NPM NPM% | 18.8 | 9.8 | -21.4 | -4.3 | 10.7 | 10.5 | 14.1 | 15.5 |
| 97.5 | 60.5 | -4.4 | -1.1 | 6.0 | 8.8 | 15.5 | 19.7 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 263 | 315 | 314 | 394 | 854 | 1,284 | 1,754 | 2,100 |
Growth Revenue Growth% | 19.6 | -0.4 | 25.5 | 117.0 | 50.4 | 36.6 | 46.3 | |
| 182 | 223 | 353 | 375 | 699 | 1,020 | 1,354 | 1,600 | |
| 81 | 92 | -39 | 18 | 155 | 264 | 400 | 500 | |
OPM OPM% | 30.6 | 29.1 | -12.5 | 4.7 | 18.1 | 20.6 | 22.8 | 23.8 |
| 18 | 10 | 17 | 25 | 19 | 4 | 8 | 14 | |
Interest Expense Interest ExpenseCr | 6 | 9 | 10 | 19 | 31 | 37 | 42 | 41 |
Depreciation DepreciationCr | 18 | 29 | 34 | 36 | 39 | 37 | 45 | 57 |
PBT PBTCr | 74 | 63 | -66 | -11 | 103 | 195 | 321 | 417 |
| 25 | 32 | 1 | 6 | 12 | 60 | 74 | 92 | |
PAT PATCr | 49 | 31 | -67 | -17 | 91 | 134 | 247 | 325 |
Growth PAT Growth% | -37.9 | -318.7 | 74.8 | 638.9 | 47.6 | 83.6 | 89.4 | |
NPM NPM% | 18.8 | 9.8 | -21.4 | -4.3 | 10.7 | 10.5 | 14.1 | 15.5 |
| 97.5 | 60.5 | -4.4 | -1.1 | 6.0 | 8.8 | 15.5 | 19.7 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 5 | 5 | 5 | 5 | 15 | 15 | 17 | 17 |
Reserves ReservesCr | 335 | 369 | 300 | 281 | 370 | 526 | 1,272 | 1,400 |
| 78 | 111 | 184 | 361 | 573 | 786 | 836 | 953 | |
| 12 | 53 | 71 | 102 | 152 | 124 | 202 | 377 | |
| 430 | 538 | 560 | 750 | 1,109 | 1,451 | 2,327 | 2,761 | |
| 265 | 340 | 328 | 502 | 763 | 1,063 | 1,682 | 1,747 | |
| 166 | 198 | 231 | 248 | 346 | 388 | 645 | 1,014 | |
| 430 | 538 | 560 | 750 | 1,109 | 1,451 | 2,327 | 2,761 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 5 | 5 | 5 | 5 | 15 | 15 | 17 | 17 |
Reserves ReservesCr | 335 | 369 | 300 | 281 | 370 | 526 | 1,272 | 1,400 |
| 78 | 111 | 184 | 361 | 573 | 786 | 836 | 953 | |
| 12 | 53 | 71 | 102 | 152 | 124 | 202 | 377 | |
| 430 | 538 | 560 | 750 | 1,109 | 1,451 | 2,327 | 2,761 | |
| 265 | 340 | 328 | 502 | 763 | 1,063 | 1,682 | 1,747 | |
| 166 | 198 | 231 | 248 | 346 | 388 | 645 | 1,014 | |
| 430 | 538 | 560 | 750 | 1,109 | 1,451 | 2,327 | 2,761 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 5 | 62 | -63 | -75 | 21 | 159 | 205 | |
| -84 | -46 | -55 | -34 | -69 | -65 | -410 | |
| 80 | 52 | 63 | 123 | 44 | -40 | 283 | |
Net Cash Flow Net Cash FlowCr | 1 | 67 | -55 | 14 | -4 | 55 | 78 |
Free Cash Flow Free Cash FlowCr | 6 | 62 | -63 | -75 | 21 | 91 | -24 |
CFO To PAT CFO To PAT% | 11.1 | 200.9 | 93.3 | 442.6 | 23.1 | 118.5 | 83.1 |
CFO To EBITDA CFO To EBITDA% | 6.8 | 67.3 | 159.7 | -404.2 | 13.6 | 60.2 | 51.2 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 5 | 62 | -63 | -75 | 21 | 159 | 205 | |
| -84 | -46 | -55 | -34 | -69 | -65 | -410 | |
| 80 | 52 | 63 | 123 | 44 | -40 | 283 | |
Net Cash Flow Net Cash FlowCr | 1 | 67 | -55 | 14 | -4 | 55 | 78 |
Free Cash Flow Free Cash FlowCr | 6 | 62 | -63 | -75 | 21 | 91 | -24 |
CFO To PAT CFO To PAT% | 11.1 | 200.9 | 93.3 | 442.6 | 23.1 | 118.5 | 83.1 |
CFO To EBITDA CFO To EBITDA% | 6.8 | 67.3 | 159.7 | -404.2 | 13.6 | 60.2 | 51.2 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 12,727 | 28,451 | ||||||
Price To Earnings Price To Earnings | 51.7 | 87.1 | ||||||
Price To Sales Price To Sales | 7.3 | 13.6 | ||||||
Price To Book Price To Book | 9.9 | 20.1 | ||||||
EV To EBITDA EV To EBITDA | 31.7 | 57.3 | ||||||
GPM GPM% | 76.9 | 76.1 | 56.4 | 57.8 | 60.3 | 64.0 | 62.9 | 62.9 |
OPM OPM% | 30.6 | 29.1 | -12.5 | 4.7 | 18.1 | 20.6 | 22.8 | 23.8 |
NPM NPM% | 18.8 | 9.8 | -21.4 | -4.3 | 10.7 | 10.5 | 14.1 | 15.5 |
ROCE ROCE% | 22.0 | 15.9 | -11.7 | 1.3 | 16.6 | 24.1 | 22.7 | 25.2 |
ROE ROE% | 14.5 | 8.2 | -22.0 | -5.9 | 23.6 | 24.8 | 19.1 | 22.9 |
ROA ROA% | 11.5 | 5.7 | -12.0 | -2.3 | 8.2 | 9.3 | 10.6 | 11.8 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 12,727 | 28,451 | ||||||
Price To Earnings Price To Earnings | 51.7 | 87.1 | ||||||
Price To Sales Price To Sales | 7.3 | 13.6 | ||||||
Price To Book Price To Book | 9.9 | 20.1 | ||||||
EV To EBITDA EV To EBITDA | 31.7 | 57.3 | ||||||
GPM GPM% | 76.9 | 76.1 | 56.4 | 57.8 | 60.3 | 64.0 | 62.9 | 62.9 |
OPM OPM% | 30.6 | 29.1 | -12.5 | 4.7 | 18.1 | 20.6 | 22.8 | 23.8 |
NPM NPM% | 18.8 | 9.8 | -21.4 | -4.3 | 10.7 | 10.5 | 14.1 | 15.5 |
ROCE ROCE% | 22.0 | 15.9 | -11.7 | 1.3 | 16.6 | 24.1 | 22.7 | 25.2 |
ROE ROE% | 14.5 | 8.2 | -22.0 | -5.9 | 23.6 | 24.8 | 19.1 | 22.9 |
ROA ROA% | 11.5 | 5.7 | -12.0 | -2.3 | 8.2 | 9.3 | 10.6 | 11.8 |
| Market CapitalizationMkt CapCr | 41,458 | 38,677 | 35,499 | 28,451 | 22,440 | 20,461 | 18,275 |
| Close PriceClose₹ | 3,317.70 | 2,408.90 | 2,184.40 | 1,718.70 | 822.65 | 1,040.95 | 1,317.20 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 32.82 | 53.22 | 86.55 | 87.07 | 28.47 | 24.25 | 25.60 |
| Price To SalesPS | 6.67 | 9.32 | 9.46 | 13.55 | 3.81 | 2.41 | 5.49 |
| RevenueRevenueCr | 6,217 | 4,148 | 3,751 | 2,100 | 5,895 | 8,477 | 3,330 |
| Revenue Growth TTMRev Gr TTM% | 25.0% | 5.9% | 25.7% | 46.3% | 21.8% | 19.7% | 11.1% |
| PAT Growth TTMPAT Gr TTM% | 29.7% | 7.6% | 894.1% | 89.4% | 39.1% | 32.9% | 60.0% |
| Market CapitalizationMkt CapCr | 41,458 | 38,677 | 35,499 | 28,451 | 22,440 | 20,461 | 18,275 |
| Close PriceClose₹ | 3,317.70 | 2,408.90 | 2,184.40 | 1,718.70 | 822.65 | 1,040.95 | 1,317.20 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 32.82 | 53.22 | 86.55 | 87.07 | 28.47 | 24.25 | 25.60 |
| Price To SalesPS | 6.67 | 9.32 | 9.46 | 13.55 | 3.81 | 2.41 | 5.49 |
| RevenueRevenueCr | 6,217 | 4,148 | 3,751 | 2,100 | 5,895 | 8,477 | 3,330 |
| Revenue Growth TTMRev Gr TTM% | 25.0% | 5.9% | 25.7% | 46.3% | 21.8% | 19.7% | 11.1% |
| PAT Growth TTMPAT Gr TTM% | 29.7% | 7.6% | 894.1% | 89.4% | 39.1% | 32.9% | 60.0% |